Skip to main content
. Author manuscript; available in PMC: 2023 Aug 25.
Published in final edited form as: Pain Physician. 2021 Mar;24(2):175–184.

Table 2.

Markers in IR in 13 cases of FM.

Case Age G HbA1c Insulin Gluc QUICKI HOMA Central Pain Score
1 35 F 5.3 15.2 105.4 0.31 4 10
2 51 F 5.7 4.5 93 0.38 1 Not avail
3 61 F 5.8 62.5 93 0.27 14.4 Not avail
4 53 F 6 4.7 85 0.38 1 18
5 62 F 5.7 20.6 97 0.3 4.9 15
6 37 M 5.8 12.8 99 0.32 3.1 17
7 55 F 5.4 39 100 0.28 9.6 15
8 41 F 5.3 17.5 114 0.23 4.9 30
9 43 M 6 13 93 0.32 3 17
10 19 F 5.4 9.4 83 0.35 1.9 17
11 43 F 6.1 16 105 0.31 4.1 Not avail
12 57 F 6.9 18.5 144 0.29 6.6 18
13 65 M 5.7 23.7 97 0.3 5.7 13

Values of HbA1c, QUICKI and HOMA-IR in 13 patients with FM. All 13 patients with FM had at least one abnormal value pointing to IR (i.e., QUICKI, HOMA, or HbA1c). In this subgroup, there were 4 patients with HbA1c below 5.6%, but each of these 4 patients showed abnormal QUICKI and HOMA indices, consistent with IR. Conversely, 2 patients with normal QUICKI and HOMA values showed abnormal levels of HbA1c. G: Gender.